Moderna CEO at Davos: Moderna Was Working on COVID Vaccine in Jan. 2020, Before COVID-19 Was Named

When did Moderna start developing its COVID-19 vaccine? Moderna’s CEO Stephane Bancel already made headlines at World Economic Forum’s (WEF) elitist Davos 2023 conference by saying he wants an mRNA vaccine factory on every continent and by confirming his negotiations with the Chinese Communist Party (CCP) to bring Moderna’s COVID-19 vaccines to China. But there’s more: Bancel admitted on CNBC at Davos that Moderna was already working on a COVID-19 vaccine in January 2020 before the virus had reached most countries and before it even had a specific name.

Bancel went on CNBC at Davos to discuss a new Moderna RSV vaccine. But something far more interesting slipped out. “I’d like to go back,” the CNBC host said excitedly. “‘Cause the last time we were here in Davos in the winter it was January 2020, and I saw you at that point, and we were at a breakfast.”

Bancel smiled. “I remember.”

The CNBC host continued enthusiastically, “You came up to me in this small room and you were talking about how you had actually the — you were working on a vaccine for — for COVID. And at that point COVID-19 didn’t even really exist in our minds.”

Bancel, still smiling, tacitly confirmed the story by agreeing, “I think there was no name at that time.” So Moderna was somehow developing a vaccine for an unnamed virus before it reached most countries outside China?